明治ＨＤ（2269） – (Progress of disclosure matters) Notice regarding Company Split and Transfer of Agricultural Chemicals Manufacturing and Sales Business

January 4, 2022 Name of Company: Meiji Holdings Co., Ltd. Name of Representative: Kazuo Kawamura, CEO, President and Representative Director Code Number: 2269, 1st Section, Tokyo Stock Exchange (Progress of disclosure matters) Notice regarding Company Split (Absorption-Type Company Split) and Transfer of Agricultural Chemicals Manufacturing and Sales Business (Change of Second-Generation Subsidiary) Meiji Holdings Co., Ltd. (hereinafter referred to as the “Company”) hereby announces completion of the transaction with Mitsui Chemicals Agro, Inc. (hereinafter referred to as “Mitsui Chemicals Agro”). The transaction is associated with the Agricultural Chemicals Manufacturing and Sales Business (hereinafter referred to as the “Business”; the assets include all shares of Meiji Agro Chemical Co., Ltd. and Meiji Pharma Korea Co., Ltd. which are wholly owned subsidiaries of Meiji Seika Pharma Co., Ltd.) operated by Meiji Seika Pharma Co., Ltd. (hereinafter referred to as “MSP”). The transaction was announced in “Notice regarding Company Split (Absorption-Type Company Split) and Transfer of Agricultural Chemicals Manufacturing and Sales Business (Change of Second-Generation Subsidiary)” dated September 10, 2021, and also in “(Amendment in disclosure items) Notice regarding Company Split (Absorption-Type Company Split) and Transfer of Agricultural Chemicals Manufacturing and Sales Business (Change of Second-Generation Subsidiary)” dated December 27, 2021. 1. Overview The Company hereby announces its completion of previously announced transaction that (i) MSP, the Company’s consolidated subsidiary, have a newly established, wholly owned subsidiary of it named MMAG Co., Ltd. (hereinafter referred to as “NewCo”) succeed the Business through an absorption-type company split, and thereafter that (ii) MSP shall transfer all shares of NewCo to Mitsui Chemicals Agro which is wholly owned subsidiaries of Mitsui Chemicals, Inc. today, in line with the schedule. 2. Future Prospects There is no revision to the consolidated earnings forecast for the fiscal year ending March 31, 2022 from the notice of “Revisions to Financial Forecasts for the Fiscal Year Ending March 31, 2022” dated November 9, 2021. ##### Disclaimer: This English translation is prepared for the readers’ convenience. When there are any discrepancies between the original Japanese version and English translation version, the original Japanese version always prevails.